Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kabir B. Nigam"'
Publikováno v:
Antioxidants, Vol 12, Iss 3, p 780 (2023)
High uric acid is associated with gout, hypertension, metabolic syndrome, cardiovascular disease, and kidney disease. URAT1 (SLC22A12), originally discovered in mice as Rst, is generally considered a very selective uric acid transporter compared to o
Externí odkaz:
https://doaj.org/article/9c155f2865bf419a810a6594df4fb60f
Autor:
Anisha K. Nigam, Anupam A. Ojha, Julia G. Li, Da Shi, Vibha Bhatnagar, Kabir B. Nigam, Ruben Abagyan, Sanjay K. Nigam
Publikováno v:
Pharmaceutics, Vol 13, Iss 10, p 1720 (2021)
In patients with liver or kidney disease, it is especially important to consider the routes of metabolism and elimination of small-molecule pharmaceuticals. Once in the blood, numerous drugs are taken up by the liver for metabolism and/or biliary eli
Externí odkaz:
https://doaj.org/article/67ab79b568474328b45abe4929c23e26
Autor:
Kabir B. Nigam, Ananda K. Pandurangi
Publikováno v:
SN Comprehensive Clinical Medicine. 3:1385-1395
The utility of hallucinogenic drugs within psychiatry is an emerging topic, although not entirely a novel idea. After their introduction to western society in the mid-twentieth century, psychologists and psychiatrists studied their properties for use
Autor:
Christopher Zhu, Kabir B Nigam, Rishabh C Date, Kevin T Bush, Stevan A Springer, Milton H Saier, Wei Wu, Sanjay K Nigam
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0140569 (2015)
The SLC22 family includes organic anion transporters (OATs), organic cation transporters (OCTs) and organic carnitine and zwitterion transporters (OCTNs). These are often referred to as drug transporters even though they interact with many endogenous
Externí odkaz:
https://doaj.org/article/b9d07160c46449f3bf474c3849ec255e
Autor:
Anupam A. Ojha, Anisha K. Nigam, Julia G. Li, Da Shi, Kabir B. Nigam, Vibha Bhatnagar, Ruben Abagyan, Sanjay K. Nigam
Publikováno v:
Pharmaceutics, vol 13, iss 10
Pharmaceutics
Volume 13
Issue 10
Pharmaceutics, Vol 13, Iss 1720, p 1720 (2021)
Pharmaceutics
Volume 13
Issue 10
Pharmaceutics, Vol 13, Iss 1720, p 1720 (2021)
In patients with liver or kidney disease, it is especially important to consider the routes of metabolism and elimination of small-molecule pharmaceuticals. Once in the blood, numerous drugs are taken up by the liver for metabolism and/or biliary eli
Publikováno v:
Biological Psychiatry. 87:S257-S258
Autor:
F. Gerard Moeller, Lisa K. Straub, Edward A. Zuniga, Aysha Sami, Noelle C. Anastasio, Kathryn A. Cunningham, James M. Bjork, Kabir B. Nigam
Publikováno v:
Drug Alcohol Depend
Background Impulsivity is an established risk factor for substance use disorder (SUD). Integral to SUD recovery is proactive control (leveraging information about a potential need for behavioral restraint to marshal increased cognitive resources towa
Autor:
Jeffrey D. Esko, Kabir B. Nigam, Sanjay K. Nigam, Omai B. Garner, Kevin T. Bush, Brett E. Crawford
Publikováno v:
Journal of Biological Chemistry. 287:42064-42070
Branching morphogenesis, a fundamental process in the development of epithelial organs (e.g. breast, kidney, lung, salivary gland, prostate, pancreas), is in part dependent on sulfation of heparan sulfate proteoglycans. Proper sulfation is mediated b
Autor:
Omai B. Garner, Ding Xu, Kabir B. Nigam, Yu Yamaguchi, Kevin T. Bush, Sanjay K. Nigam, Jeffrey D. Esko
Publikováno v:
Developmental Biology. 355:394-403
Specific interactions of growth factors with heparan sulfate may function as "switches" to regulate stages of branching morphogenesis in developing mammalian organs, such as breast, lung, salivary gland and kidney, but the evidence derives mostly fro